Protein: Myocyte-specific enhancer factor 2A isoform X1 (A0A8M9PF86)
Organism: Danio rerio (Zebrafish) (Brachydanio rerio)
Subcellular location: Nucleus
InterPro domains:
- IPR022102: Holliday junction regulator protein family C-terminal (domain) [139-198]
- IPR036879: Transcription factor, MADS-box superfamily (homologous_superfamily) [2-95]
- IPR033896: MADS MEF2-like, N-terminal (domain) [2-78]
- IPR002100: Transcription factor, MADS-box (domain) [1-61]
Sequence:
MGRKKIQITRIMDERNRQVTFTKRKFGLMKKAYELSVLCDCEIALIIFNSSNKLFQYASTDMDKVLLKYTEYNEPHESRTNSDIVEKLRNKGHNDCPSPDPDDCFGHSPLMDDRFGKLNEESDLMYKRCGALNKKEHRGCDSPDPDASYVLTPHTEEKYKKINEEFDNMMRNHKIPTALPPQNFSMHVAVPVTNPNAMSYNPGASLSSQSLSAAASLSDGAMLSPPQGSMHRSVVPPQRPPSTGSTAGNGFVNPRGSPGLLGTPSGNGLGKVMPAKSPPPPGGNMGIGSRKPDLRVVIPPSSKGMMPPLSEEEEMELNTQRISSSQSTQPLATPVVSVTTPSLAPQGLVYSGMPTAYNSEYSLSSAELSSLQGFGSPGLSIGSVSAWQQHQLGQAALSSLVGGGHLPQGSNLSINTSQNVNIKSEPISPPRERVTPSGFPPQQQQPPSGRPDMGRSPVDSLSSSCSSYDGSDREDHRPDFHSPLGLGRPPAGGADERESPSVKRMRMDTWVT
Predicted GO terms:
Molecular Function (MF): GO:0003674 (molecular function), GO:0005488 (binding), GO:0097159 (organic cyclic compound binding), GO:1901363 (heterocyclic compound binding), GO:0003676 (nucleic acid binding), GO:0003677 (DNA binding), GO:0001067 (transcription regulatory region nucleic acid binding), GO:0003690 (double-stranded DNA binding), GO:0043565 (sequence-specific DNA binding), GO:0000976 (transcription cis-regulatory region binding), GO:1990837 (sequence-specific double-stranded DNA binding)
Biological Process (BP): GO:0008150 (biological process), GO:0048518 (positive regulation of biological process), GO:0050789 (regulation of biological process), GO:0032501 (multicellular organismal process), GO:0065007 (biological regulation), GO:0032502 (developmental process), GO:0009987 (cellular process), GO:0048869 (cellular developmental process), GO:0048856 (anatomical structure development), GO:0007275 (multicellular organism development), GO:0009653 (anatomical structure morphogenesis), GO:0019222 (regulation of metabolic process), GO:0007389 (pattern specification process), GO:0071840 (cellular component organization or biogenesis), GO:0048646 (anatomical structure formation involved in morphogenesis), GO:0048522 (positive regulation of cellular process), GO:0050794 (regulation of cellular process), GO:0009893 (positive regulation of metabolic process), GO:0030029 (actin filament-based process), GO:0032989 (cellular component morphogenesis), GO:0044085 (cellular component biogenesis), GO:0010604 (positive regulation of macromolecule metabolic process), GO:0048468 (cell development), GO:0030154 (cell differentiation), GO:0048731 (system development), GO:0048513 (animal organ development), GO:0060255 (regulation of macromolecule metabolic process), GO:0030036 (actin cytoskeleton organization), GO:0009891 (positive regulation of biosynthetic process), GO:0061061 (muscle structure development), GO:0001756 (somitogenesis), GO:0009888 (tissue development), GO:0003002 (regionalization), GO:0031325 (positive regulation of cellular metabolic process), GO:0009889 (regulation of biosynthetic process), GO:0051171 (regulation of nitrogen compound metabolic process), GO:0009790 (embryo development), GO:0016043 (cellular component organization), GO:0031323 (regulation of cellular metabolic process), GO:0080090 (regulation of primary metabolic process), GO:0010927 (cellular component assembly involved in morphogenesis), GO:0051173 (positive regulation of nitrogen compound metabolic process), GO:0035282 (segmentation), GO:0010556 (regulation of macromolecule biosynthetic process), GO:0055001 (muscle cell development), GO:0010628 (positive regulation of gene expression), GO:0061053 (somite development), GO:0030239 (myofibril assembly), GO:0010468 (regulation of gene expression), GO:0022607 (cellular component assembly), GO:0010557 (positive regulation of macromolecule biosynthetic process), GO:0045935 (positive regulation of nucleobase-containing compound metabolic process), GO:0051254 (positive regulation of RNA metabolic process), GO:0042692 (muscle cell differentiation), GO:0072359 (circulatory system development), GO:0031326 (regulation of cellular biosynthetic process), GO:0019219 (regulation of nucleobase-containing compound metabolic process), GO:0051252 (regulation of RNA metabolic process), GO:0060429 (epithelium development), GO:0006996 (organelle organization), GO:0031032 (actomyosin structure organization), GO:0097435 (supramolecular fiber organization), GO:0009952 (anterior/posterior pattern specification), GO:0031328 (positive regulation of cellular biosynthetic process), GO:0007507 (heart development), GO:0009792 (embryo development ending in birth or egg hatching), GO:0070925 (organelle assembly), GO:0043009 (chordate embryonic development), GO:2001141 (regulation of RNA biosynthetic process), GO:0006355 (regulation of DNA-templated transcription), GO:0007010 (cytoskeleton organization), GO:0051146 (striated muscle cell differentiation), GO:1902680 (positive regulation of RNA biosynthetic process), GO:0055002 (striated muscle cell development), GO:0006357 (regulation of transcription by RNA polymerase II), GO:0045893 (positive regulation of DNA-templated transcription), GO:1903508 (positive regulation of nucleic acid-templated transcription), GO:0140694 (non-membrane-bounded organelle assembly), GO:1903506 (regulation of nucleic acid-templated transcription), GO:0045944 (positive regulation of transcription by RNA polymerase II)
Cellular Component (CC): GO:0005575 (cellular component), GO:0110165 (cellular anatomical entity), GO:0005622 (intracellular anatomical structure), GO:0043226 (organelle), GO:0043229 (intracellular organelle), GO:0043227 (membrane-bounded organelle), GO:0043231 (intracellular membrane-bounded organelle), GO:0005634 (nucleus)